Related content

MALDI-TOF mass spectrometry-based SNP genotyping

By Pusch Wolfgang   Wurmbach Jan-Henner   Thiele Herbert   Kostrzewa Markus  

Pharmacogenomics, Vol. 3, Iss. 4, 2002-07 ,pp. : 537-548

Future Medicine

Access to resources Recommend Favorite

Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes

By Hein David W   Doll Mark A  

Pharmacogenomics, Vol. 13, Iss. 1, 2012-01 ,pp. : 31-41

Future Medicine

Access to resources Recommend Favorite

A four-SNP NAT2 genotyping panel recommended to infer human acetylator phenotype

By Hein David W   Doll Mark A  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 855-855

Future Medicine

Access to resources Recommend Favorite

Accuracy of NAT2 SNP genotyping panels to infer acetylator phenotypes in African, Asian, Amerindian and admixed populations

By Suarez-Kurtz Guilherme   Vargens Daniela D   Sortica Vinicius A   Hutz Mara H  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 851-854

Future Medicine

Access to resources Recommend Favorite

High Fidelity SNP Genotyping Using Sequence-Specific Primer Elongation and Fluorescence Correlation Spectroscopy

By  

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 6, 2003-12 ,pp. : 477-484

Bentham Science Publishers

Access to resources Recommend Favorite